Note: Not all studies are available based on copyrights of the original documents. Please note the PARI Pharma copyright studies are owned by PARI Pharma. Data may not be referenced in any way including print and electronic formats without the prior written consent of PARI Pharma.

[ECFC 06-08 07] U. Schuschnig, E. Klopfer, A. Krüner, R. Schmid, M. Keller Colistin CF for aerosol therapy of the upper airways. An in-vitro deposition study with the PARI SINUS 31st European Cystic Fibrosis Conference, Prague, Czech Republic, June 11-14, 2008
[ECFC 06-08 06] E. Bitterle, A. Luithlen, K. Reul, D. Mueller, M. Keller Aerosol Characteristics of Hypertonic Saline (HS) nebulised by the eFlow® rapid 31st European Cystic Fibrosis Conference, Prague, Czech Republic, June 11-14, 2008
[ECFC 06-08 05] M. Tservistas, K. Hoyer, S. Seemann, M. Keller, M. Knoch Aerosol Characteristics of eFlow® using different control units 31st European Cystic Fibrosis Conference, Prague, Czech Republic, June 11-14, 2008